Cargando…
High expression levels of egfl7 correlate with low endothelial cell activation in peritumoral vessels of human breast cancer
Tumor blood vessels participate in the immune response against cancer cells and we previously used pre-clinical models to demonstrate that egfl7 (VE-statin) promotes tumor cell evasion from the immune system by repressing endothelial cell activation, preventing immune cells from entering the tumor m...
Autores principales: | Pannier, Diane, Philippin-Lauridant, Géraldine, Baranzelli, Marie-Christine, Bertin, Delphine, Bogart, Emilie, Delprat, Victor, Villain, Gaëlle, Mattot, Virginie, Bonneterre, Jacques, Soncin, Fabrice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950557/ https://www.ncbi.nlm.nih.gov/pubmed/27446447 http://dx.doi.org/10.3892/ol.2016.4791 |
Ejemplares similares
-
Egfl7 Is Differentially Expressed in Arteries and Veins during Retinal Vascular Development
por: Poissonnier, Loïc, et al.
Publicado: (2014) -
VE-statin/egfl7 Expression in Endothelial Cells Is Regulated by a Distal Enhancer and a Proximal Promoter under the Direct Control of Erg and GATA-2
por: Le Bras, Alexandra, et al.
Publicado: (2010) -
Egfl7 promotes tumor escape from immunity
por: Pinte, Sébastien, et al.
Publicado: (2012) -
A Functional γδTCR/CD3 Complex Distinct from γδT Cells Is Expressed by Human Eosinophils
por: Legrand, Fanny, et al.
Publicado: (2009) -
Transcriptional regulation of blood vessel formation: The role of the CASZ1/Egfl7/RhoA pathway
por: Charpentier, Marta S, et al.
Publicado: (2013)